These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2022455)

  • 21. Polymeric contrast agents for MR imaging of adrenal glands.
    Weissleder R; Wang YM; Papisov M; Bogdanov A; Schaffer B; Brady TJ; Wittenberg J
    J Magn Reson Imaging; 1993; 3(1):93-7. PubMed ID: 8428107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals.
    Baxter AB; Melnikoff S; Stites DP; Brasch RC
    Invest Radiol; 1991 Dec; 26(12):1035-40. PubMed ID: 1722486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and applications for macromolecular Gd-based contrast agents.
    Brasch RC
    Magn Reson Med; 1991 Dec; 22(2):282-7; discussion 300-3. PubMed ID: 1725917
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo MR evaluation of Gd-DTPA conjugated to dextran in normal rabbits.
    Li KC; Quisling RG; Armitage FE; Richardson D; Mladinich C
    Magn Reson Imaging; 1992; 10(3):439-44. PubMed ID: 1383670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular mapping using albumin-(Gd-DTPA), an intravascular MR contrast agent, and projection MR imaging.
    Moseley ME; White DL; Wang SC; Wikström MG; Dupon JW; Gobbel G; Roth K; Brasch RC
    J Comput Assist Tomogr; 1989; 13(2):215-21. PubMed ID: 2925907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of magnetic susceptibility and MR contrast agent concentration.
    Weis J; Nilsson S; Ericsson A; Wikström M; Sperber GO; Hemmingsson A
    Magn Reson Imaging; 1994; 12(6):859-64. PubMed ID: 7968285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtracted synthetic images in Gd-DTPA enhanced MR.
    Suto Y; Caner BE; Tamagawa Y; Matsuda T; Kimura I; Kimura H; Toyama T; Ishii Y
    J Comput Assist Tomogr; 1989; 13(5):925-8. PubMed ID: 2778158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity.
    Frank JA; Choyke PL; Girton ME; Austin HA; Sievenpiper C; Inscoe SW; Black JL; Carvlin MJ; Dwyer AJ
    J Comput Assist Tomogr; 1989; 13(3):448-59. PubMed ID: 2723175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary oxygen toxicity: demonstration of abnormal capillary permeability using contrast-enhanced MRI.
    Brasch RC; Berthezène Y; Vexler V; Rosenau W; Clément O; Mühler A; Kuwatsuru R; Shames DM
    Pediatr Radiol; 1993; 23(7):495-500. PubMed ID: 8309747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and Size-selective Permeability of the Synovial Membrane of the Temporomandibular Joint of the Mouse Measured by MR Imaging at 7T.
    Yamazaki F; Satoh K; Seo Y
    Magn Reson Med Sci; 2015; 14(2):115-22. PubMed ID: 25500776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.
    Unger E; Needleman P; Cullis P; Tilcock C
    Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging of acute myocardial infarction in pigs using Gd-DTPA.
    Wikström M; Martinussen HJ; Wikström G; Ericsson A; Nyman R; Waldenström A; Hemmingsson A
    Acta Radiol; 1990 Nov; 31(6):619-24. PubMed ID: 2278789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging.
    Matsumura A; Shibata Y; Yamamoto T; Nakagawa K; Yasuda S; Nakajima S; Sakata I; Yoshizawa T; Nose T
    Neurol Med Chir (Tokyo); 1997 Apr; 37(4):327-31. PubMed ID: 9136556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3D-MR-angiography using Gd-DTPA].
    Seiderer M; Bauer WM; Villringer A; Einhäupl K
    Rofo; 1990 Mar; 152(3):327-32. PubMed ID: 2157258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhancing properties of Gd-DTPA at 2.0 Tesla.
    Schmiedl U; Moseley MM; Ogan MD; Chew WM; Brasch RC
    Radiat Med; 1987; 5(1):1-5. PubMed ID: 3628851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vivo.
    Norman AB; Thomas SR; Pratt RG; Samaratunga RC; Sanberg PR
    Brain Res; 1989 Nov; 503(1):156-9. PubMed ID: 2611648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.
    Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Moseley M; Watson A; Rocklage S
    Invest Radiol; 1991 Nov; 26 Suppl 1():S250-2; discussion S253-4. PubMed ID: 1808141
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI of blood-brain barrier permeability in astrocytic gliomas: application of small and large molecular weight contrast media.
    Schmiedl UP; Kenney J; Maravilla KR
    Magn Reson Med; 1991 Dec; 22(2):288-92. PubMed ID: 1812359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.